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Abstract  
Hypochlorous acid (HOCl), produced in inflammatory conditions by the enzyme 
myeloperoxidase, and its anion, perchlorite ( OCl-) exist in vivo at almost equal 
concentrations. Their reactions with hyluronan and heparin (as a model for sulphated 
glycosaminoglycans in the extracellular matrix), have been studied as a function of pH. 
The major product in these reactions is the chloramide derivative of the 
glycosaminoglycans. Spectral, chloramide yield and kinetic measurements show sharply 
contrasting behaviour of heparin and hyaluronan and the data allow the calculation of 
second-order rate constants for the reactions of both HOCl and OCl- for all reaction 
pathways leading to the formation of chloramides and also oxidation products . By 
comparison with hyaluronan, it can be  demonstrated that both N-sulphate and O-sulphate 
groups in heparin  influence the proportions of these pathways in this glycosaminoglycan. 
Evidence is also given for further oxidation pathways involving a reaction of HOCl with 
the chloramide product of hyaluronan but not with heparin. The significance of these 
results for mechanisms of inflammation, particularly for fragmentation of extracellular 
matrix glycosaminoglycans is discussed. 
 
Introduction 
The extracellular matrix ( ECM) is made up of huge multi-molecular complexes with 
arrays of link proteins and aggrecan molecules along a central hyaluronan backbone.  
Hyaluronan (HA) is bound by a number of ECM and cell surface proteins including 
aggrecan, versican, and tumor necrosis factor alpha stimulated gene 6 (TSG-6) [1,2]. 
With this central structural function, HA is a particularly important component of the 
ECM [3, 4], as demonstrated by the fact that hyaluronan synthase-2 knockout is 
embryonically lethal in mice [5]. HA also provides a hydrated environment [6] for 
growing, moving and renewing cells and tissues [7], activates signalling events in cells 
and is involved in moderating many cellular processes including proliferation, migration, 
adhesion and  apoptosis [8-11] . HA appears to have a range of significant biological 
functions dependent upon its molecular mass. Large molecular mass fragments are 
involved in space-filling and immunosuppressive roles, whilst smaller HA fragments 
have been shown to be pro-inflammatory and angiogenic ; oligosaccharides may be 
involved in cell signalling (reviewed in [12]). 
Oxidative damage of the extracellular components by either enzymatic or non-enzymatic 
pathways may have implications for the initiation and progression of a range of human 
diseases. These include arthritis, kidney disease, cardiovascular disease, lung disease, 
periodontal disease and chronic inflammation. The potential mechanisms of oxidative 
damage in these diseases has been reviewed recently [13]. 
Oxidative damage to hyaluronan by reactive oxidative species, and in particular free 
radicals, has received much attention, largely through the ease of monitoring its 
fragmentation using viscometric techniques. Much of this early work has been reviewed 
[14].  
The focus of HA studies in our laboratories has been to measure HA fragmentation yields 
as a proportion of quantifiable fluxes of free radicals produced by ionising radiation. For 
this purpose, both viscosity changes and a combination of gel permeation 
chromatography with multi-angle laser light scattering have been used to measure 
changes in molecular weight of the polydisperse hyaluronan. In this way, the efficiencies 
of fragmentation of HA by a range of free radicals and reactive oxidative species 
including hydroxyl radicals, carbonate radicals, dibromide and dichloride radical anions 
and peroxynitrite have been determined [15,16]. 
The fragmentation of hyaluronan has also been investigated intensively by Davies and 
co-workers using both electron paramagnetic resonance and sensitive PAGE techniques. 
The use of the latter technique showed the novel and exciting result that hypochlorite 
reacts largely in a site-specific process to produce an array of HA fragments, in a “ladder-
type display” each separated from the neighbour by the molecular mass of the repeating 
disaccharide unit in HA, thus mimicking to a significant extent the action of the enzyme, 
hyaluronidase [17,18]. Using the PAGE technique, similar site-specific reactions were 
also observed by Davies and co-workers for oxidation of several glycosaminoglycans by 
peroxynitrous acid, carbonate and hydroxyl radicals [19,20]. Equally significant for the 
understanding of potential molecular mechanisms involved in inflammation is the 
demonstration in these studies that hypochlorite species form chloramides when they 
react with amides [21] and in particular, with glycosaminoglycans [17,18,22]. Here, a 
substitution reaction occurs where the N-H group becomes an N-Cl group. At sites of 
inflammation where myeloperoxidase can form hypochlorous acid, the potential 
formation of such derivatives may accelerate the fragmentation of glycosaminoglycans 
within the extracellular matrix. Chloramides are weak oxidising agents and therefore are 
potential biological targets for reducing radicals and other reducing agents. Indeed, it has 
been shown that superoxide radicals cause the fragmentation of HA via reaction with HA 
chloramide [18]. It is also a possibility that an N-Cl group presents a more reactive target 
to strong oxidising agents such as the hydroxyl and carbonate radicals, perhaps leading to 
efficient site-specific fragmentation.  
HOCl has a pKa value of 7.59 [23,25] and therefore at physiological pH there is 
approximately a 50:50 mixture of the acid and its anion OCl-. In principle therefore, both 
species can participate in the substitution reaction to form chloramides. However, most if 
not all of the fragmentation and kinetic studies on glycosaminoglycan chloramides  have 
been carried at pH 7.4 . In these studies,  it is implicit that substitution is the major 
process. HOCl is also a strong oxidising agent [29])  and there is clearly the potential for 
it and its anion counterpart to engage in oxidative reactions, particularly in hydrogen 
abstraction, the dominant mechanism in fragmentation of glycosaminoglycans. It may be 
therefore that both substitution and oxidation reactions occur simultaneously. It may also 





 Figure 1 Structures of hyaluronan,  heparin, N-acetylglucosmaine and D-glucosamine-2-
N-sulphate. 
It is the main purpose of this study to investigate both the kinetic reactivity and reaction 
profiles of the two species , HOCl and OCl- with both hyaluronan and heparin, the latter 
being a model for sulphated glycosaminoglycans of the extracellular matrix.  Although 
these two biopolymers have similar  structures (see Figure 1), they have large differences 
in charge density since heparin contains several sulphate groups, on average 2-3 per 
disaccharide unit. It is anticipated that this study of the reactivity of these contrasting 
structures will lead to a basis for prediction of the modes of reaction of the hypochlorite 
species with glycosaminoglycans, particularly to differentiate the response of sulphated 
and non-sulphated glycosaminoglycans in the extracellular matrix and also to assess 
whether chloramide formation may accelerate fragmentation via subsequent site-specific 
oxidation by the hypochlorous species. 
Materials and methods 
Hyaluronan (45kDa) was provided as a gift by Novozymes. Heparin (porcine) was 
purchased from Alfa Aesar and Sigma Aldrich. Solutions were prepared in chelex-treated 
buffers of 0.1 M phosphate (pH 6.5 to 8.5) allowing sufficient time to fully hydrate the 
glycosaminoglycans. Hypochlorous acid (Sigma) solutions were prepared freshly and the 
concentrations of stock solutions determined using the extinction coefficient of the 
hypochlorite ion of 350 M-1 cm-1 at pH values 10 or above [25]. 
The reactions of hypochlorous acid with heparin and hyaluronan were investigated by 
simple mixing experiments conducted at 37°C. Absorption spectrophotometry in the 
range 200 nm to 400 nm was used to monitor the progress of the reactions. Yields of the 
respective chloramides were determined using TNB ( 5-thio-2-nitrobenzoic acid, Sigma 
Aldrich) assays  after first quenching the reaction with excess taurine. Dilutions of the 
quenched reactions were selected to match the 35-45 μM concentrations of TNB. After 
30 minutes incubation, the absorbance of the TNB thiol oxidation product was measured 
at 412 nm (extinction coefficient =  13600 M-1 cm-1 [21]). 
Glycosaminoglycan samples were analysed to determine the extent of fragmentation of 
the biopolymers using the modified Min and Cowman PAGE method [26,27].  10% and 
20% polyacrylamide gels (0.1x16x20 cm) were run using a Bio-Rad Protean II xi multi 
cell system. 15μl of sample was added to 5μl of loading buffer (10x TBE buffer, 1M 
tris/0.25M borate/0.01M EDTA) containing 2M sucrose. This 20μl volume was loaded 
onto gels covered with 1x TBE running buffer. For hyaluronan samples, the gels were run 
at 125V (20mA) for 20 minutes then at 250V (40mA) for approximately 80 minutes or 
until the bromophenol blue tracking dye approached the gel bottom. For heparin samples, 
the gels were run for 7 to 10 hours at 100 V. The gels were immediately transferred to 
non-stick trays after the run and were soaked with 0.5% alcian blue dissolved in 
deionised water for 30 minutes in the dark. The gels were then de-stained in deionised 
water after which they were scanned using a high resolution scanner ,(Epson Perfection 
V500 Photo flatbed scanner, 6400 dpi x 9600 dpi). The captured images were visualised 
and digitised using Quantiscan ® software.  
The gpc/MALLS system used for the determination of the molecular weight and 
molecular weight distribution of heparin and hyaluronan comprised a solvent distribution 
system, Model 6000A (Waters Division of Millipore, USA) connected to a Hemabio 
linear (10µm) steel column packed with hydrophilic modified HEMA gel. Injection into 
the gpc/MALLS system was achieved using a manual Rheodyne model 7125 syringe-
loading sample injector equipped with a 1ml sample loop and a concentration detector. 
The Wyatt Optilab DSP interferometric refractometer operated at 632.8 nm equipped 
with a 10-mm P100 cell (Wyatt Technology Corp., USA). The DAWN DSP laser light 
scattering photometer was equipped with a 632.8-nm He/Ne laser (Wyatt Technology 
Corp.) with 15 detectors calibrated with filtered toluene and normalized with pullulan 
(23.8 kDa) obtained from Polymer Standards Services. The pullulan was also used to 
determine the volume delay between detectors. A value of 0.150 was used for the 
refractive index increment (dn/dc). Data accumulation and analysis was achieved using 
Wyatt Technology ASTRA 4.9.07software. All measurements were performed at room 
temperature. 
 
Results and Discussion 
Yields of heparin and hyaluronan chloramides 
a) 1 mM hypochlorite experiments: In order to minimise the possibility of  sequential 
secondary reactions of hypochlorite with the products of the reaction between 
hypochlorite and heparin or hyaluronan, relatively low concentrations of 1 mM 
hypochlorite solutions containing approximately 5 or 10 mM glycosaminoglycan were 
used to give  1:5 or 1:10 ratios of hypochlorite to glycosaminoglycan (where hypochlorite 
represents both HOCl and OCl- species). The concentrations of hyaluronan and heparin 
were calculated using the molecular mass of the repeating disaccharide units. For heparin, 
which has some diversity in its structure, the concentrations, unless otherwise stated, 
were based on a repeat unit of molecular mass of 592. Such solutions at pHs 6.5 to 8.5 
were incubated at 37°C for between 180 minutes and 440 minutes (heparin) and up to 
600 minutes (hyaluronan) and then quenched by the addition of excess taurine (at 
concentrations which ensured formation only of taurine monochloramine and not the 
dichloramine). Changes in the absorbances at 251 nm (the absorption maximum of 
taurine monochloramine ; ε =  429 M-1 cm-1 [21]) and at 292 nm (the absorption 
maximum of both hypochlorite species [29]) allowed the calculation of unreacted 
hypochlorite concentrations.  A TNB assay for total chloramide and chloramine (from the 
added taurine) was also undertaken for each reacted solution. 
Heparin: Figure 2a shows the absorption spectra measured at pHs 6.5 to 8.5 at the end of 
the reactions for 5 mM heparin solutions after subtraction of contributions from unreacted 
heparin and any residual hypochlorite.  The presence of an additional absorbing species is 
seen at 270 nm consistent with that of heparin chloramide as found in a previous study at 
pH 7.4 [22]. The absorbances at 270 nm show a clear effect of pH with higher values 
being measured at the lower pHs as shown in Figure 2b. The effect of pH on the % yield 
of the chloramide , as measured by the TNB assay,  is shown in Figure 2c.  This also 
shows a clear pH effect with a 94% yield at pH 6.5 decreasing to 60 % at pH 8.5. On the 
assumption that most of the absorption at 270 nm is attributable to the chloramide, the 
TNB assay data at pH 6.5, where a 94% yield of chloramide was measured,  can be used 
to calculate an extinction coefficient for the chloramide at 270nm – here an estimate of 
75 +/- 10  M-1 cm-1 was made. From these experiments, it is clear that the reaction of 
hypochlorite with heparin produces significant concentrations of reaction products other 
than the chloramide. The high chloramide yield at pH 6.5 (94%) indicates that the 
reaction of neutral hypochlorous acid to produce the chloramide  is faster than any 
oxidation processes. The substitution reaction is clearly favoured despite the high 
oxidation potential of hypochlorous acid (standard reduction potential, 1.49 V) [24]. At 
pH 8.5, where the negatively charged hypochlorite ion, OCl- is predominant, it would 
appear that the N(H)-SO3- group hinders the substitution reaction rate making the 
possibility of oxidation processes more likely. The effect on the substitution rate constant 
must be considerable since oxidation rates by hypochlorite ions could be expected to be 







 Figure 2  Absorption spectra measured at :   a) 180 minutes at 37°C  of the reaction 
mixtures of 1 mM hypochlorite and 5  mM heparin at pHs 6.5 to 8.5 . A, pH 6.5 ; B, pH 
7.0; C pH 7.5; D, pH 8.0; E, pH 8.5 (2 cm path length;  after subtraction of contributions 
from unreacted heparin and residual hypochlorite)  b)  Absorbance values at 270nm 
measured as in a), ♦ before subtraction of unreacted heparin, ◊, after subtraction of 
unreacted heparin ;  c) % reaction yields as a function of pH  in a 1 mM hypochlorite, 
9.67 mM heparin reaction mixture (◊) and in a 5mM hypochlorite and 9.67 mM heparin 
mixture (♦) 
 
Hyaluronan: In similar experiments with hyaluronan, the spectra at 300 minutes after the 
start of the reaction of 1 mM HOCl with 10 mM hyaluronan (after subtraction of 
contributions due to unreacted hyaluronan and hypochlorite) were found to be similar in 
shape at the five pHs studied (pH 6.5 to 8.5) differing only due to small residual amounts 
of unreacted hypochlorite. It was clear that the reaction proceeded at a faster rate at 
higher pHs and so Figure 3 shows only the spectrum at pH 8.5 measured at the end of the 
reaction. The spectrum shows a broad absorption in the range 240 to 290 nm. At this pH, 
where a 100% reaction was measured, the extinction coefficient of the chloramide 
product was calculated as  80 +/- 5 M-1 cm-1 at 250 nm .  
 
 Figure 3   Absorption spectrum measured at 300 minutes of the reaction mixtures at 
37°C of 1 mM hypochlorite and 10 mM hyaluronan at pHs  8.5 , (path length = 1 cm; 
after subtraction of contributions from unreacted hyaluronan and residual hypochlorite. 
 
The effect of pH on the yield of the chloramide measured in TNB assays showed that the   
yield is close to 100% at all pHs indicating that a simple reaction to form the chloramide 
occurs with little or no evidence of other reaction pathways, such as those involving 
oxidation.. This observation is in sharp contrast to the mechanism described above for 
heparin. In hyaluronan, there are no SO3- groups and so the reactions of both 
hypochlorous acid and its anion, hypochlorite with the uncharged N(H)-acetyl group to 
form only the chloramide are favoured over oxidation processes.  
b) 5mM hypochlorite experiments The effect of pH upon the yields of heparin and 
hyaluronan chloramides was also investigated by incubating solutions at 37°C of 5mM  
hypochlorite and approximately 10mM solutions of the glycosaminoglycan in 0.1M 
phosphate buffers. This facilitated the measurement of both hypochlorite and chloramide 
and increased the probability of a secondary reaction of hypochlorite with the 
chloramide.  For heparin, the reactions were monitored for up to 440 minutes. For 
hyaluronan, the reactions were much slower and were followed for a minimum of 10 
hours. For both hyaluronan and heparin, this ensured that the reactions went to at least 
80% completion. The reactions were then quenched by the addition of excess taurine. 
Changes in the asborbances at 251 nm (the absorption maximum of taurine 
monochloramine) again allowed the calculation of unreacted hypochlorite concentrations.  
For hyaluronan the absorbance at 292nm can be considered a reliable measure of 
unreacted HOCl due to the relatively low extinction coefficients of chloramides and other 
products. A TNB assay for total chloramides was conducted for each reacted solution. 
Heparin  Figure 4a shows the spectra obtained for heparin solutions at pH values 6.5 to 
8.5 at 180 minutes (pH 6.5 to 7.5) and at 440 minutes (pH 8.0 and 8.5) after the initiation 
of the reactions. Contributions to the spectra from unreacted hypochlorite and heparin 
have been subtracted. The characteristic maximum at 270 nm for the heparin chloramide 
species [22] is seen clearly at pH 6.5 and, relative to this spectrum, it is seen that increase 
of pH leads to a decrease in the absorption at 270 nm together with a reduction in the 
sharpness of the maximum. At pH 6.5, the TNB assay (Figure 2c) showed that at least 
90% of hypochlorite species had reacted to form the chloramide of heparin.  Using the 
data at pH 6.5 in Figure 4a, the extinction coefficient of heparin chloramide at 270 nm 
was determined as 90  +/-  5 M-1 cm-1.  Adjusting the pH in the pH 6.5 experiment after 
the reaction was completed through to pH 8.5 produced no detectable change in either 
absorption maximum or intensity (data not shown), demonstrating that heparin 
chloramide is not involved in any acid-base equilibria in this pH range. The lack of such 
an effect of pH had been also observed for some other chloramines and chloramides [21]. 
Therefore, the spectral changes in Figure 4a appear to reflect lower yields of heparin 
chloramide as the pH is increased together with an increasing spectral contribution from 
other products whose absorption is less intense and without character in this wavelength 
range. Thus, in Figure 4b, the absorbance at 270nm (after subtraction of small 
contributions due to unreacted heparin and residual hypochlorite) is seen to decrease from 
0.42 to 0.23 as the pH is increased to 8.5. The effect of pH on chloramide yields at the 
higher hypochlorite concentration is shown in Figure 2c. It is clear that the pH profiles in 
Figures 4b and 2c are very similar in shape and demonstrate clearly that the yield of 
heparin chloramide decreases to about 60% value as the pH is increased to 8.5. The 270 
nm absorbance data and the % chloramide yield  data also show identical decreases, 
within experimental error, as pH increases to those found in the 1mM hypochlorite/ 5mM 
heparin experiments (see Figures 2b and 2c). This correlation suggests that hypochlorite 
reacts with heparin via at least two reaction pathways, one to form the chloramide and the 
other(s) to form oxidation products. The identical yields of heparin chloramide found for 
both 1mM and 5mM hypochlorite reactions with 9.67mM heparin at all pHs indicate that 
reactions which occur subsequently to the formation of the chloramide do not affect the 
yield within the experimental error limits.  
  
Figure 4  a) Absorption spectra measured at 180 minutes at 37°C for pHs 6.5, 7.0 and 7.5 
and at 440 minutes for pHs 8.0 and 8.5 for the reaction mixtures of 5 mM hypochlorite 
and 9.67 mM heparin  A, pH 6.5 ; B, pH 7.0; C pH7.5; D, pH8.0; E, pH8.5 (path length = 
1 cm;  after subtraction of contributions from unreacted heparin and residual 
hypochlorite); b) Effect of pH on the absorbance at 270nm in figure 4a.(♦, ◊; before and 
after subtraction of unreacted heparin contributions respectively). 
 
Hyaluronan  The spectra at the end of the reactions in the pH range 6.5 to 8.5 had similar 
shapes, differing only in minor contributions from residual hypochlorite. Again, the 
reaction at pH 8.5 proceeded more quickly than other pHs and the spectrum at this pH is 
accordingly shown in Figure 5a. The apparent extinction coefficient of the chloramide 
(and other products) at 250 nm  at pH 8.5, was thus calculated as  80 +/- 5 M-1  cm-1  i.e. 
similar to the value of 75  M-1 cm-1 found in the 1mM hypochlorite experiment. This 
similarity may indicate that any non-chloramide products do not absorb significantly at 
250 nm. The yields of hyaluronan chloramide at pHs 6.5 to 8.5, determined using the 
TNB assay are shown in Figure 5b. In contrast to heparin, the yields increase with 
increase in pH and are much less than the 100% yields found using 1mM hypochlorite 
and 10mM hyaluronan solutions.  
 
 Figure 5  a)  Absorption spectra measured at 330 minutes at 37°C for  the reaction 
mixtures of 5 mM hypochlorite and 10 mM hyaluronan at pH 8.5  (contributions to the 
spectra of unreacted hypochlorite and hyaluronan have been subtracted), 1 cm pathlength 
; b) Effect of pH on the TNB assays of the solutions in figure 5a. Also shown are the 
chloramide yields expressed as a % of the concentration of hypochlorite which has 
reacted.  x denotes the simulated yields of chloramide using the denoted k ( hypochlorite 
+ HA) values in figure 7c together with the k (hypochlorite + HACl ) values in figure 8b. 
 
It is clear that at this higher hypochlorite concentration, significant proportions of 
hypochlorite (35 to 65% as the pH decreases from 8.5 to 6.5) are involved in reactions 
other than chloramide formation, such as oxidation. However, it has been shown from 
experiments using 1mM hypochlorite, where reactions of hypochlorite with reaction 
products are less likely, that hypochlorite reacts with hyaluronan to produce 100% yields 
of the chloramide. It would appear therefore that the significantly reduced yields of 
chloramide found at the higher hypochlorite concentration must occur subsequently to 
chloramide formation. An obvious candidate is the reaction of hypochlorite with the 
chloramide product. 
It is clear from the above experiments with both heparin and hyaluronan that pH has a 
definite and strong effect on the spectra and yields of the products of the reaction of 
hypochlorite. 
The most probable explanations for the above observations in 5mM hypochlorite 
solutions containing either 10mM heparin or hyaluronan are: a) the chloramides are 
sufficiently unstable at 37°C that they decompose during the reaction times studied to 
obtain the yield data; b) there is some reaction between the product chloramides and 
hypochlorite occurring over the timescale of yield data measurements; c) the  
hypochlorite species have different reaction modes depending on the differing 
proportions of OCl- and HOCl reactions with glycosaminoglycans, the principal modes 
being that of substitution to form the chloramides and that of oxidation. These 
possibilities will now be explored further using data collected in stability, kinetic and 
fragmentation experiments.  
 
Thermal stability of heparin and hyaluronan chloramides 
The stability of approximately 8mM heparin chloramide solutions was monitored, using 
the TNB assay, for up to 21 hours at 37° C. There was little or no change, at any of the 
pHs studied, in chloramide concentration . The effect of pH on chloramide yield 
discussed above is therefore unlikely to arise as a result of thermal instability. In 
experiments at room temperature and at 4°C, heparin chloramide showed considerable 
stability with little change after several days at room temperature or even weeks at 4°C. 
The thermal stability of hyaluronan solutions at 37°C has already been investigated at pH 
7.4 [17] where it was shown that 1.6mM solutions showed no degradation over 24 hours. 
In our studies in the pH range 6.5 to 8.5 using 1mM hypochlorite and 10mM hyaluronan, 
100% yields of chloramide were measured at the end of the reaction and at times 
covering all measurements of yields made throughout this study. This supports the earlier 
study at pH 7.4 [17]. As with heparin chloramide, hyaluronan chloramide was shown to 
be remarkably stable at 4°C, showing little or no decay even after 21 days of storage. 
These stability measurements demonstrate quite clearly that any yields of either heparin 
or hyaluronan chloramides determined in this study which are less than 100% can not 
arise from thermal instability.  
From the data already presented above, it would appear that the hypochlorite species, 
HOCl and OCl-, react with heparin via at least two pathways, one to produce the 
chloramide and the other to produce oxidation products. The proportions of these 
pathways at a particular pH are identical, within experimental error, for both 1mM and 
5mM hypochlorite solutions; any reaction of hypochlorite with the product heparin 
chloramide which would be favoured at the higher hypochlorite concentration must be 
insignificant. As the yield of chloramide has been shown to decrease with increasing in 
pH from 94% to 60%, HOCl is more effective at producing the chloramide. Conversely, 
OCl- is much less effective and produces a significant amount of oxidation (40% at pH 
8.5). Since HOCl is the predominant species at pH 6.5 (90%) and OCl-  is predominant at 
pH 8.5 (90%), the reactions of these species may be summarised as follows: 
 HOCl + Hep => HepCl  ; k1      (1) 
 HOCl + Hep => HepOx ;  k2     (2) 
 OCl- + Hep => HepCl ; k3     (3) 
 OCl- + Hep => HepOx ; k4     (4) 
In sharp contrast, hyaluronan chloramide yields are not affected by pH when 1mM 
hypochlorite solutions are used, where 100% yields are measured. When 5mM 
hypochlorite solutions are used however, the yields of chloramide increase with increase 
in pH. It is clear therefore that there must be an additional reaction pathway at the higher 
hypochlorite concentration. The most likely one is the reaction of hypochlorite with the 
product, chloramide. It is also apparent that oxidation of hyaluronan by HOCl is more 
effective than oxidation by the anion, OCl-  since lower chloramide yields are measured 
at pH 6.5. These observations can be summarised as follows:  
 HOCl + HA => HACl ; k5     (5) 
 HOCl + HA => HAOx ; k6     (6) 
 OCl- + HA => HACl ; k7     (7) 
 OCl- + HA => HAOx ; k8  ;   (8) 
 HOCl + HACl => products ; k9    (9) 
 OCl- + HACl => products ; k10    (10) 
The contrast between heparin and hyaluronan in these experiments demonstrates clearly 
the effect of the N(H)-SO3- group in determining the reactivity of heparin towards both 
chloramide production and oxidation. The negative charge on the sulphate group hinders 
particularly the reaction of OCl-, favouring oxidation over chloramide production despite 
the low oxidation potential of the hypochlorite anion relative to hypochlorous acid , 
HOCl (see earlier).  In the following section, kinetic data will be presented to support the 
above mechanisms.  
Effect of pH upon reaction kinetics in hypochlorite/ glycosaminoglycan solutions. 
Changes in pH in the range 6.5 to 8.5  affect the rates of reaction of hypochlorite with 
heparin and hyaluronan since the species, HOCl and OCl-, can be expected to react at 
different rates [29] and in different modes of reaction, probably to form the chloramides 
and oxidation products. Where hypochlorite species may also be involved in reactions 
with these products, particularly with the chloramides as secondary processes, there can 
also be an effect of pH upon the kinetic reactivity. The latter reaction could for example, 
account for the lower yields of hyaluronan chloramides obtained in this study at high 
hypochlorite to hyaluronan concentration ratios. The following experiments were thus 
performed with a view to calculating the rate constants for these various modes of 
reaction.  
Kinetic studies in 1mM hypochlorite solutions. To minimise the extent of the reaction of 
hypochlorite with chloramide species, reactions were generally conducted using low 
hypochlorite concentrations, (1mM) and relatively high glycosaminoglycan 
concentrations  (5 or 10mM). This approach had the additional advantage of being able to 
analyse the decay of absorbance attributable to hypochlorite species at 292 nm using a 1st 
order kinetics analysis, as adopted in an earlier study [22]. Kinetic experiments were thus 
conducted with heparin and hyaluronan by following the decay of hypochlorite species at 
292nm in solutions containing 1 mM hypochlorite reacting with both 5 and 10 mM 
glycosaminoglycan in buffered solutions.   
In the case of heparin, there is a significant residual absorbance at the end of the reaction 
attributable to the chloramide and perhaps other products. Plots of  ln(At - A∞) versus 
time, t , where At and A∞ represent the absorbances at time t and at the end of the reaction 
respectively, were used and found to be linear. From the slope of such plots, the decay 
rate constant in s-1 was determined and thus the second order rate constants were 
calculable. At pH 6.5, the extinction coefficients of heparin chloramide and hypochlorite 
species at 292nm were too similar and it was necessary to use other wavelengths, 
particularly 240nm, for the kinetic analysis.  
 In support of the above approach to a pseudo first-order reaction, kinetic simulations 
were also carried out using the IBM Chemical Kinetics Simulator, IBM No 1906. To do 
this, the extinction coefficients of hypochlorite, heparin and chloramide (+ other 
products) were needed. At reaction completion, following subtraction of absorbances 
from unused reactants, the extinction coefficients of the chloramide (and products) were 
calculated. Both types of kinetic analysis produced the same values of rate constants 
within experimental error and these are shown in Figure 6a. The second-order rate 
constants in this figure are based upon the concentration of N(H)-SO3- groups in heparin , 
using the value of 88.6 per 100 residues as reported elsewhere [28]. The dominant 
reactivity of this entity was confirmed by reacting 4.9mM hypochlorite with 5mM N-
sulphate groups (in heparin) at pH8.5 at room temperature and monitoring the decay of 
absorbance at 330nm . With almost equal concentrations of reactants and little or no 
contributions to the absorbance from the products expected at pH8.5, the decay should 
follow second-order kinetics as demonstrated by the  linear plot of 1/ absorbance v time 
shown in Figure 6b (the figure also shows the fitted linear plot). The rate constant was 
determined from the both the slope of the linear plot ( = k/l. ε , where ε is the extinction 
coefficient of hypochlorite species at this pH and l is the path length). The value 
determined in this way, 0.032 M-1 s-1. 
 
 
Figure 6 The effect of pH on the second order rate constants for the reaction of 
hypochlorite and heparin, a) for the reaction of 1mM hypochlorite  with  9.67 mM 
heparin (◊) and for the reaction of 5mM hypochlorite with 9.67 mM heparin (♦) ( the 
latter obtained from kinetic simulations, see text); b) a plot of 1/OD @ 330nm v time for 
a 4.9 mM hypochlorite , 5. mM N-sulphate (in heparin) reaction mixture at pH 8.5 at 
room temperature (also shown is the linear fit for this plot); c) the effect of pH on the 
second order rate constants for the reaction of 1mM hypochlorite with 10 mM hyaluronan 
(also shown is the fit expected assuming a pKa of hypochlorous acid of 7.6). x denotes 
the rate constant values which, together with the k (hypochlorite + HACl) values in figure 
8b, are  used to simulate chloramide yields in figure 5b . 
 
From Figure 6a, there is a distinct effect of pH on the second order rate constant with 
values of 0.13 +/- 0.01 M-1 s-1 at pH 6.5 decreasing to a value of 0.02 +/- 0.05  M-1 s-1  at 
pH 8.5. This trend appears to correlate with the pKa of hypochlorous acid which has a 
pKa of 7.6  [25]. This data can be fitted to the following equation;  
 kobs = (ka [H+] + kb 10-pKa) / ( [H+] + 10-pKa)    (11) 
where kobs is the second-order rate constant at a particular pH, ka and kb are  the second-
order rate constants for the reaction of HOCl and OCl- respectively with either heparin or 
hyaluronan. This equation is appropriate for a fast equilibrium between HOCl and OCl- 
with slower reactions of the two species with either heparin or hyaluronan. Fitting the 
data yields values for reactions (1) – (4), as follows: 
 k1 + k2 = 0.15 M-1 s-1  and  
 k3 + k4 = 0.006 M-1 s-1   
The second-order rate constants in Figure 6a are consistent with the earlier value of 0.051 
+/- 0.02 M-1 s-1 measured at pH7.4 at 37°C [22]. 
For hyaluronan, rate constants were determined, as with heparin, by both assuming 
pseudo first-order kinetics and by simulation. Unlike heparin chloramide however, the 
extinction coefficient of hyaluronan chloramide at 292 nm was relatively small (15 M-1 
cm-1) and this made the simulation process more precise. The resultant rate constants are 
shown in Figure 6c. Again, in contrast to heparin, increase in pH leads to an increase in 
the second-order rate constant. Fitting the data in Figure 6c to equation (11), yielded the 
following values: 
 k5 + k6 = 0.01 M-1 s-1  and  
 k7 + k8 = 0.017 M-1 s-1   
The second-order rate constants in Figure 6c are consistent with the earlier value of 0.012 
+/- 0.03 M-1 s-1 measured at pH 7.4 at 37°C [22]. 
Kinetic studies in 5mM hypochlorite solutions: 
Heparin  5mM hypochlorite was reacted with 9.67mM heparin solutions at pHs between 
6.5 and 8.5 and the decay of absorbance followed at 292nm for all pHs with the exception 
of pH 6.5 where, because of the similarity in extinction coefficients of hypochlorite and 
heparin chloramide at 292nm, the reaction was studied instead at both 240nm and 310nm. 
Here, only kinetic simulation of the decay was used to determine the k (hypochlorite + 
heparin ) rate constant, based on the assumption of the single reaction (12) – which is 
equivalent to reactions (1) –(4): 
 hypochlorite + heparin => HepCl + products    (12) 
As in the case of the 1mM hypochlorite experiments, the simulations had to take into 
account the significant contribution of absorbance of the chloramide (and other products ) 
at 292nm. The apparent extinction coefficient of the chloramide at 292nm decreased with 
increase in pH due to the increasing contribution of the much weaker absorbance from 
oxidation products. The apparent extinction coefficient was calculated, as with the 1mM 
solutions, from the absorbance at the end of the reaction, allowing for any absorbance for 
small residual amounts of hypochlorite and any unreacted heparin. These extinction 
coefficients had much smaller experimental errors (+/- 5%) than the ones measured in the 
1 mM hypochlorite solutions where contributions from unreacted heparin were a major 
contribution to final absorbances measured. The simulations to yield the rate constants 
for reaction (12)  for both 1mM and 5mM hypochlorite were carried out using these more 
reliable values. For both solutions, the values selected were within the errors of each type 
of experiment. The resultant rate constants are shown in Figure 6a alongside the 1mM 
hypochlorite rate constants. The similarity in values at each pH indicates that there is 
little or no need to invoke a reaction between hypochlorite and heparin chloramide. 
Hyaluronan  Similar experiments were conducted for 10mM hyaluronan solutions 
containing 5mM hypochlorite. As before, the decay kinetics of hypochlorite were 
followed at 292nm unlike heparin, the contributions from absorbances of hyaluronan 
chloramide and products were much smaller. From absorbances at the end of the 
reactions at pHs from 6.5 to 8.5, there was little or no effect of pH on the absorbances 
measured. Taking into account that the chloramide yields have already been shown to 
vary significantly over this pH range it was assumed, that at 292nm, there was little 
difference in the extinction coefficients of the chloramide and other products. A value of 
15 +/- 5 M-1 cm-1 was therefore estimated for both. Using these values, it was clear that it 
was not possible to use the value of the rate constant  of 9.5 +/- 1.5 x 10-3  M-1 s-1 
(measured in 1mM hypochlorite solutions) at pH6.5 to simulate the experimental decay at 
292nm seen in 5mM hypochlorite solutions . The slower decay in Figure 7a shows the 
simulated plot assuming a rate constant of  9.5 x 10-3 M-1 s-1 which is much slower than 
the actual experimental decay. At pH7, a similar, but much less marked, effect was seen. 
At higher pHs, the experimental decays could be simulated within experimental error 
using the rate constants obtained in the 1mM hypochlorite experiments. Further kinetic 
simulations were therefore carried out at all pHs by considering the following reactions: 
 hypochlorite + HA => HACl + products    (13) 





Figure 7 a) The decay of absorbance at 292nm observed in a solution of 5 mM 
hypochlorite containing 10 mM hyaluronan at pH 6.5. Also shown is the simulated fit for 
k (hypochlorite + HA) = 9.5 x 10-3 M-1 s-1 and k (hypochlorite + HACl) = 2.8 x 10-2 M-1 
s-1  b) the effect of pH on k (hypochlorite + HACl ), see text. 
 
Reactions (13) and (14) are equivalent to reactions (5) to (10). Figure 7a shows therefore 
the simulated decay which matches the experimental decay at pH 6.5. In this example, 
k(13) is 9.5 x 10-3  M-1 s-1 and k(14) is 2.8 x 10-2  M-1 s-1 . Although there is no analytical 
solution to equations (13) and (14) to give a decay of absorbance equation which could 
produce coefficients of correlation between such an equation and the experimental decay, 
repeat simulations using k(13) values within the experimental error were carried out with 
a range of k(14) values. Here a reasonable fit was assessed using only simulated decay 
plots which were within +/- 5 % at the beginning of the decay and +/- 10% at the end of 
the decay (where smaller absorbances are observed). In this way, k(14) values could be 
estimated for other pH values. This method was not particularly sensitive unless k(14) is 
particularly high as at pH6.5 since the reaction of hypochlorite only begins to have an 
effect on the decay at 292nm when sufficient chloramide has accumulated to react as in 
reaction (14). The effect on the decay at values of k(14) lower than about 1 x 10-2 M-1 s-1 
is only seen towards the end of the decay. For pHs 7.5 to 8.5, values of  k(14) ranging 
from zero to 1 x 10-2  M-1 s-1  would also provide reasonable fits to the experimental 
decays.  
The yields of hyaluronan chloramide in contrast , however, are very sensitive to the 
values of k(14) as may be expected and as was demonstrated by trial simulations. Figure 
7b therefore shows the effect of pH on the k(14) values which fitted both the kinetic 
decays at 292nm and also the chloramide yields. The fits to the yields are shown in 
Figure 5b. The k(13) rate constant values used together with rate constants in Figure 7b to 
predict the chloramide yields were within the experimental error of the values determined 
in Figure 6c and are shown there as discrete points. Taken together, the k(14) data in 
Figure 7b provide reasonable fits to both kinetic and yield data obtained in the 5mM 
hypochlorite solutions. 
From the chloramide yield data and kinetic data presented in this study, it is now possible 
to calculate rate constants for the individual reactions, (1) to (10). Thus, since k1 + k2 = 
0.15 M-1 s-1  and k3 + k4 = 0.006 M-1 s-1 and the yields of chloramide are 94 % and 40% 
respectively for the k1 and k3 reaction pathways, it can be calculated, for example, that k1 
= 0.14 M-1 s-1  . Similar calculations can be done for k1 to k8 and these are shown in Table 
1. Fitting of the data in Figure 7b in equation (11) and assuming the pKa of hypochlorous 
acid to be 7.4, yields k ( HOCl + HACl) and k ( OCl- + HACl) values of 3.0 x 10-2  M-1 s-








Reaction Rate constant ( M-1 s-1) 
HOCl + Hep => HepCl    0.14 
HOCl + Hep => HepOx 9 x 10-3 
OCl- + Hep => HepCl 4 x 10-3 
OCl- + Hep => HepOx 2 x 10-3 
HOCl + HA => HACl 1 x 10-2 
HOCl + HA => HAOx < 5 x 10-4
OCl- + HA => HACl 1.7 x 10-2
OCl- + HA => HAOx < 8 x 10-4
HOCl + HACl => products 3 x 10-2 
OCl- + HACl => products 6 x 10-3 
HOCl + D-Gluc-2-N-SO3- 0.6 
OCl- + D-Gluc-2-N-SO3- 0.06 
HOCl + D-acetylglucosamine 8 x 10-3 
OCl- + D-acetylglucosamine 3.6 x 10-3 
 
Table 1 Rate constants of selected reactions of HOCl and OCl- with heparin, hyaluronan , heparin chloramide, hyaluronan 
chloramides, N-acetylglucosamine and D-glucosamine-2-N-sulphate. 
 
An alternative approach to investigating the reaction of hypochlorite with heparin and 
hyaluronan chloramides was also considered. This concerned the prior synthesis of the 
chloramides and then reacting these with hypochlorite in a subsequent experiment. 
Heparin chloramide was synthesised in high yield (6.2mM)  at pH 6.5 where the 
chloramide yield is highest and the % oxidation products would be only 6% . The pH of 
the solution was then adjusted to pH 8.5 where the rate of reaction of hypochlorite with 
heparin chloramide could be expected to be greatest in that the lowest chloramide yields 
are measured at this pH, perhaps as a result of a reaction between hypochlorite and 
heparin chloramide. Simulation of the decay of absorbance in these solutions containing 
2 mM hypochlorite was undertaken. Figure 8 shows two such simulations using the 
extinction coefficients of the chloramide appropriate to pH 6.5 and assuming that the 
extinction coefficient of the products of any reaction between hypochlorite and heparin 
chloramide was relatively low compared to the extinction coefficient of hypochlorite. 
This latter assumption is supported by the effect of pH on the end of reaction spectra at 
pH8.5, see Figure 2a for example. The slowest simulated decay, where the rate constant 
for hypochlorite reacting with the chloramide was set as a very low value of 1 x 10-4, 
matches the experimental one and demonstrates this reaction is not needed to account for 
the kinetic decay and indeed, such a reaction is not needed to account for the yields or 
spectra obtained in 5mM hypochlorite solutions. The second simulated decay shown in  
Figure 8, which shows a small departure from the fitted plots, assumes that k ( 
hypochlorite + HepCl) = 1 x 10-3  M-1 s-1 .Thus, the range of the latter rate constant is 
effectively zero to 1 x 10-3  M-1 s-1   . Further simulation  of the chloramide yields showed 
that the higher value does not change the chloramide yield that would otherwise be 
predicted. All kinetic, spectral and yield data when taken together provide little or no 
evidence for a significant reaction between hypochlorite and heparin chloramide under 
the conditions of this study. An upper limit of 1 x 10-3 M-1 s-1 can be estimated for this 
reaction. 
 
Figure 8 The decay of absorbance at 292 nm in a solution containing 2 mM hypochlorite 
and 6.2 mM heparin chloramide  at pH 8.5 ((♦)experimental data; A;  k (hypochlorite + 




For hyaluronan, high yields, close to 100%, of the chloramide could only be obtained in 1 
mM hypochlorite solutions containing 10mM hyaluronan. Consideration of the rate 
constants for the competition of hypochlorite for both hyaluronan and its chloramide 
indicate that at pH 6.5, where k (hypochlorite + HACl) is highest at 2.8 x 10-2 M-1 s-1, 
there would only be an approximately 15 % increase in the initial decay rate of the 
absorbance at 292nm. A simulation of such an experiment at pH6.5, where solutions 
containing 1mM HACl and 9mM hyaluronan are reacted with 2mM hypochlorite showed 
only small differences in the kinetic decay at 292nm. This is attributed not only to the 
low concentration of chloramide but also to the relatively low extinction coefficient of 
hypochlorite at this pH and the fact that the competition produces both an increase in 
chloramide absorbance as well as a reduction, due to the chloramide reaction with 
hypochlorite.  
Fragmentation yields  
An earlier study showed that synthesis of hyaluronan chloramide produced little or no 
effect on the PAGE scan relative to that of hyaluronan itself. i.e.  no fragmentation of the 
chloramide could be detected [17].  In contrast, in this study ,the effect of pH on yields of 
the chloramides provides evidence  for oxidation pathways which might be expected to 
produce fragmentation of the glycosaminoglycan chloramides. To investigate this further,  
PAGE studies were conducted on the potential for fragmentation arising via the synthesis 
of hyaluronan and heparin chloramides . In these studies, the Rf values of the stained 
scans have been calibrated against the molecular mass of the glycosaminoglycans using a 
gpc/MALLS combination (see Materials and Methods).  
Figures 9a and 9b show scans for heparin at pH 6.5 and hyaluronan at pHs in the range 
6.5 to 8.5, (pH did not seem to have a marked effect on heparin as almost identical scans 
were generated at pH 8.5 (data not shown). In these experiments, the ratios of 
hypochlorite and heparin are such that the chloramide preparation should be seen as a 
heavily-substituted heparin polymer - with a parallel scenario envisaged  for hyaluronan.  
The probability of the existence of discrete unsubstituted heparin or hyaluronan 
molecules under these conditions would be extremely small. Thus, in Figure 9a, where 
the heparin chloramide concentration was 6.2mM, approximately 6 out of 10 N(H)-SO3- 
residues in the polymer would be substituted by Cl whereas in the hyaluronan gel 
experiments (Figure 9b) approximately 1 out of 10 N(H)-acetyl residues would be 
substituted. The gel scans show clearly that fragmentation occurs in the reactions of 
hypochlorite with both heparin and hyaluronan. Using the calibrated gels, the number and 
weight average molecular masses can be calculated for both control samples and the 
chloramide substituted polymers using the equations; 
Mn=ΣHi/Σ(Hi/Mi)       and  Mw= Σ(HiMi)/ΣHi 
where Hi is the intensity of the blue stain in the gels at discrete Mi (molecular mass) 
values and where Mi has been calibrated using the gpc/MALLS equipment. The number 
of chain breaks per polymer molecule can then be calculated from the Mn data, as 
follows: 
 Chain breaks per molecule = (Mn0 – Mnp) / Mnp 
  
Figure 9  a) PAGE scans of solutions containing 9.67 mM heparin control at pH 6.5 (A) ;  
heparin chloramide (from reaction of 9.67 mM heparin with 9 mM hypochlorite at pH 
6.5) (B), (The gels were run for 8 h 30 minutes at 100V using  20 % polyacrylamide); b) 
PAGE scans of:  10 mM hyaluronan and  of 1mM hypochlorite solutions containing 10 
mM hyaluronan at pH 6.5 , 7.5 and 8.5. (The gels were run for 4 hours using 20% 
acrylamide). 
 
The concentration of chain breaks ( M) is then given by : 
 [Chain breaks] = chain breaks per molecule x [polymer control]  
This data is summarised in Table 2. 
System Mn (kDa) Mw (kDa) CB/molecule [CB] 
Hep control, pH 6.5 13.3 14.8 Not applicable Not applicable 
Hep control, pH 8.5 13.3 14.8 Not applicable Not applicable 
HepCl, pH 6.5 12.2 13.2 0.09 41 μM 
HepCl, pH 8.5 12.2 13.2 0.09 41 μM 
HA control 43.4 57.0 Not applicable Not applicable 
HACl, pH 6.5 37.1 50.7 .17 1.6 μM 
HACl, pH 7.5 35.6 50.1 .22 2.0 μM 
HACl, pH 8.5 37.0 51.8 .17 1.6 μM 
Table 2 Mn , Mw and chain break yield data for heparin and hyaluronan chloramides. 
The concentration of chain breaks found in the heparin chloramide - containing solutions 
was calculated as 41µM at both pHs 6.5 and 8.5 , equivalent to only 0.4% of the reacted  
hypochlorite. So although oxidation processes consume between about 6% (at pH6.5) and 
40% (at pH8.5) of the hypochlorite, it would appear that oxidation does not lead to any 
significant fragmentation of  heparin, in contrast to high efficiencies of fragmentation 
found when oxidising free radicals react with hyaluronan, as previously observed [16]. 
The concentration of chain breaks determined in the preparation of hyaluronan 
chloramide solutions, although low at 1.6-2.0μM, was easily detected in the PAGE scans 
. In spite of the fact that the yields of chloramide were found to be 100% in these 1mM 
hypochlorite solutions at any pH in the range 6.5 to 8.5, these chain break data indicate 
that a very small percentage, 0.16-0.20 %, of hypochlorite is actually used to produce 
fragmentation. This small amount would not be detected in a reduction of the TNB yield, 
being well within the detection error limits of the assay.  It may be that this small 
proportion of hypochlorite does react via an oxidative pathway with very low rate 
constants (limits given in Table 1); An equally plausible possibility is perhaps the 
reaction of hypochlorite with impurities such as residual copper ions, despite the attempt  
to remove such ions using ion exchange resins.   
In conclusion, PAGE is a very sensitive method to measure fragmentation of 
glycosaminglycans , however, the yields are low and it is clear that the oxidation of 
heparin and hyaluronan does not lead to significant fragmentation. 
Reaction of hypochlorite  with model monosaccharides 
In order to confirm the effect of pH on yields, spectra and kinetic reactivity already 
determined for heparin and hyaluronan  D-glucosamine-2-N-sulphate and N-
acetylglucosamine were selected as models for the hypochlorite-reactive monosaccharide 
units in heparin and hyaluronan respectively. Thus, 1mM hypochlorite was reacted with 5 
mM D-glucosamine-2-N-sulphate at pHs in the range 6.5 to 8.5. At the end of these 
reactions, when there was little or no residual hypochlorite, the chloramide yields were 
measured using the TNB assay. In contrast to heparin, 100% yields were found at all pHs 
examined. It is immediately clear therefore that the reactivity in heparin, where oxidation 
processes compete with chloramide formation, is influenced by either the presence of 
adjacent monosaccharide groups or, more likely, by the presence of sulphate groups in 
the N-sulphated residue. The yield of chloramide of only 60% in the reaction of the 
hypochlorite anion, OCl-, suggests that the presence of other sulphate groups in the most 
commonly-occurring disaccharide, the 2-O-sulphated ioduronic acid, 6-O-sulphated, N-
sulphated glucosamine provides an additional electrostatic effect preventing a 100% 
chloramide yield as found in the model compound. The 3-dimensional structure of 
heparin [31,32] shows that the 6-O-sulphate group is closer to the N-sulphate group than 
is the 2-O-sulphate group in the ioduronic acid moiety and is therefore likely to produce a 
greater negative electrostatic effect on the rate of reaction of OCl- with the N-sulphate 
group. This effect is clearly sufficient to allow an oxidation step to be preferred in 40% of 
the OCl- reaction with heparin at pH8.5, in contrast to no oxidation in the D-glucosamine-
2-N-sulphate model compound. 
Confirmation of 100% chloramide yields found using TNB data at pHs 6.5 to 8.5 was 
obtained from the end of reaction spectra where identical spectra attributable to the 
chloramide were observed at each pH with a maximum of 270nm and an extinction 
coefficient of 110 +/- 5 M-1 cm-1. Figure 10a shows a representative spectrum at pH 7.0.  
 
 
Figure 10 a)  The absorption spectrum of D-glucosamine-N-sulphate chloramide  
measured at 200 minutes in a reaction mixture containing 1 mM hypochlorite and 5 mM 
D-glucosamine-N-sulphate (path length 2 cm); b) the effect of pH on k (hypochlorite + 
D-glucosamine-N-sulphate) .  
 
 
The rate constants for the reaction of 1mM hypochlorite with 5mM D-glucosamine-2-N-
sulphate were determined by simulation at 240nm, 292nm and at 330nm. As before, the 
kinetic simulations required the extinction coefficients of the reactants and products. For 
this model, where the monosaccharide has no detectable absorption at these wavelengths, 
the process was more straightforward. The simulations at 330nm were yet more 
straightforward in that the chloramide did not absorb significantly. The effect of pH on 
the rate constants is shown in Figure 10b. From the latter, the rate constant at pH 7.5 was 
estimated as 0.25 +/- 0.01 M-1 s-1. This can be compared the value of 0.91 +/- 0.13 M-1 s-1 
found at pH7.4 in an earlier study [22]. There is no apparent reason for this discrepancy – 
however the difference is relatively large. Figure 10b also shows an unusual effect of pH 
not seen elsewhere in this study in that the rate constants cannot be fitted to equation (11) 
which takes account of the rapid equilibrium between HOCl and OCl- . It is clear that the 
rate constant of 2.0 +/- 0.1 M-1 s-1 found at pH 6.5 is much higher than the value of about 
0.5 M-1 s-1 which would otherwise be expected. An additional experiment using lower 
concentrations of both hypochlorite and heparin (both 1mM) was therefore carried out at 
pH4.0 and a kinetic simulation at 240 nm was performed. As the inset in Figure 10b 
shows, a very high rate constant of 100 +/- 10 M-1 s-1 was estimated. It was confirmed 
that the chloramide was still being produced in 100% yield. At pH4, the predominant 
species is still hypochlorous acid and thus it cannot be this which is responsible for the 
high rate constant. There is also no carboxylate function in D-glucosamine-2-N-sulphate 
and there is therefore no pKa in the model compound which could account for this pH 
effect, the N-SO3-  being too acidic. By elimination therefore the candidate appears to be 
chlorine itself or instead an acid-catalysed reaction of hypochlorous acid. Evidence for 
the latter type of reaction has not been substantiated for reactions of aqueous chlorine 
systems containing organics [29] and so reactions of Cl2aq are usually proposed instead. 
At pH4, there is however little Cl2aq; at low chloride ion concentration, the equilibrium 
constant of 5.1 x 10-4 M2 [29] would indicate a [Cl2aq] / [HOCl] of about 2 x 10-5. This 
low concentration of chlorine at pH4 implies that the rate constant at a much lower pH 
where only Cl2aq would exist, would be several orders of magnitude higher than the value 
of 100 M-1 s-1 found at pH4.0 in this study . In general, the kinetics of reactions of 
chlorine and related species have received considerable attention largely because of 
interest in water treatment but also because of the potential reactions of HOCl and OCl- 
reactions in vivo. The review of kinetics and mechanisms by Deborde and von Gunten 
[29] confirms this level of interest. Their review gives a substantial amount of kinetic 
data on reactions with amines and amides which lead to chlorination and are generally 
much faster than reactions with other categories of organics. Such studies are focussed on 
hypochlorous acid and the hypochlorite anion, with reactions of hypochlorous acid being 
faster. Some kinetic data is available in the review which shows even faster reactions for 
Cl2aq. In the case of the secondary amide, N-methylpropanamide, the respective rate 
constants for reactions of Cl2aq, HOCl and OCl- were 147, 1.7 x 10-2 and 9.2 x 10-3 M-1 s-1 
[30]. This latter findings provides some support therefore for the high rate constant 
estimated in this study for reactions of hypochlorite with D-glucosamine-2-N-sulphate at 
pH 4, and so support for a very high rate constant  ( >>102 M-1 s-1) for the reaction of 
Cl2aq with D-glucosamine-2-N-sulphate. From the data presented, and using equation 
(11), the rate constants for the reaction of  HOCl and OCl- with D-glucosamine-2-N-
sulphate could be estimated as 0.6 +/- 0.1 and 0.05 +/- 0.005 M-1 s-1 respectively. 
 
 
Figure 11 a) The spectrum of N-acetylglucosamine chloramide at pH 8.5 (measured at 
200 minutes in a  reaction mixture containing 1 mM hypochlorite and 10 mM  N-
acetylglucosamine (1 cm path length); b) the effect of pH on k (hypochlorite + N-
acetylglucosamine). Also shown is the fit to the pKa of hypochlorous acid of 7.4 
For 1mM hypochlorite reacting with the HA monosaccharide model,  10mM N-
acetylglucosamine, the reaction to form the chloramide was 100% efficient at all pHs, as 
assessed by the TNB assay. This finding supports the 100% chloramide yields found in 
1mM hypochlorite solutions containing 10mM hyaluronan. Figure 11a shows the 
spectrum of the product chloramide at the end of the reaction at pH8.5 under the same 
conditions. At 250nm, the extinction coefficient of the chloramide was estimated as 135 
+/- 10 M-1cm-1. Kinetic measurements of the reaction were again performed using the 
simulation procedure, this was more straightforward than with hyaluronan since the 
model compound had no detectable absorption at 292 nm. As with hyaluronan itself, 
increase of pH increases the rate constant – as seen in Figure 11b. At pH7.5, a value of 
0.03 +/- .003 M-1 s-1 was estimated and this can be compared to the value of 0.064 +/- 
0.003 found in an earlier study [22]. Again as in the case of D-glucosamine-2-N-sulphate, 
the heparin model compound, this rate constant estimated in the current study is 
significantly lower than in the earlier study. There is no apparent reason for this 
difference. Unlike heparin, there was no increase in the rate constant as the pH was 
decreased from 6.5 to 4.0, a result that was repeated with hyaluronan itself. It thus 
appears that Cl2aq does not compete with HOCl to chlorinate the N-acetyl group. From 
the data presented, and using equation (11), the rate constants for the reaction of HOCl 
and OCl- could be estimated as 8.0 +/- 0.08 x 10-3 and 3.6 x 10-2 M-1 s-1 respectively. 
Major features of the spectral, yields and kinetic studies: 
From this detailed study of the effect of pH on spectra, yields and kinetic reactivity for 
reactions of hypochlorite with heparin, hyaluronan and related monosaccharide model 
compounds, a number of interesting features emerge. 
The spectral and yield measurements show clear differences between the two 
glycosaminoglycans, heparin and hyaluronan. At low concentrations of hypochlorite, N-
Cl yields are 100% for hyaluronan whereas for heparin at both high and low hypochlorite 
concentrations, there are significant competitive oxidation pathways at all pHs. Thus, 
unlike heparin, the electrostatically neutral acetyl-N-H group does not provide any effect 
on the efficiency of N-Cl production in the direct reaction between hypochlorite and 
hyaluronan. In contrast, the presence of the N(H)-SO3- in heparin provides a negative 
electrostatic effect on the rate of reaction which produces the chloramide allowing 
significant proportions of hypochlorite, up to 40%, to participate in oxidation pathways. 
The PAGE studies show that such oxidation only produces fragmentation at very low 
levels for both glycosaminoglycans (e.g. 0.4 % in heparin chloramide) unlike the high 
efficiencies measured in H-abstraction from CH(OH) groups in studies of free radicals 
reacting with, for example, hyaluronan [16]. The effect of the N(H)SO3- group on the 
probability of oxidation competing with chlorination however is not seen in the model, 
D-glucosamine-2-N-sulphate providing some evidence of an additional negative 
electrostatic effect in heparin, probably from the nearest 6-O-sulphate group in the 
glucosamine-N-sulphate moiety. At high hypochlorite concentrations, oxidation becomes 
effective at all pHs for both heparin and hyaluronan with much reduced yields of N-Cl 
(more effective at low pH for hyaluronan and more effective at high pH for heparin). 
Evidence has also been presented for oxidation of the hyaluronan chloramide product by 
hypochlorous acid which is seen as the only mode of reduction of N-Cl yields at high 
hypochlorite concentration.   
The data obtained on yields of N-Cl and competing oxidative reactions has allowed the 
estimation of many individual rate constants as shown in Table 1. A major feature here is 
that HOCl chlorinates heparin much faster than does OCl- . In contrast, the opposite is 
found for hyaluronan. Both trends are also supported by studies of the model compound. 
One  explanation of these opposing trends can be gleaned from the studies of Thomm and 
Wayman on reactions of hypochlorite with aliphatic secondary amides [30]. There, it was 
proposed that N-H forms a hydrogen bond with O- (in OCl-) and that electron 
withdrawing groups weaken the N-H bond making kinetic reactivity of OCl- greater than 
that of HOCl. This is supported by the rate constants for reaction of HOCl and OCl- with 
N-methylformamide (1.7 x 10-3 and 0.21 M-1 s-1 respectively) and with N-
methylacetamide (1.7 x 10-3 and 1.8 x 10-2 M-1 s-1 respectively) [30]. With N-
methylpropanamide however, the reverse is found with OCl- (7 x 10-2 and 9.2 x 10-3 M-1 
s-1 respectively [30]). Thus, it would appear that the electron-withdrawing effect of the N-
sulphate on the N-H bond in heparin is much weaker than for the N-acetyl group in 
hyaluronan. With regard to oxidation, the kinetic data show that the oxidation by HOCl 
occurs, as expected from its greater oxidation potential, much faster than for OCl-.  
Finally, both kinetic and yield data have been used to provide evidence for an effective 
reaction between HOCl and hyaluronan chloramide, indeed this reaction is almost three 
times faster than the reaction of HOCl with hyaluronan itself. This is likely to be an 
oxidation reaction and as such may present an alternative target to reactive oxidative 
species in inflammatory processes in vivo. However, there was little or no evidence for 
such a reaction in heparin. It may be that the weak electron-withdrawing effect of the N-
sulphate group relative to that of the N-acetyl group makes removal of the Cl group in 
N(SO3-) less likely.  
 
Conclusions 
Localised excess production of HOCl has been implicated in a\number of diseases that 
involve an acute or chronic inflammatory response (e.g. atherosclerosis, rheumatoid 
arthritis and asthma) [36,43] .There is evidence that binding of myeloperoxidase to 
matrix components and cell-surface glycosaminoglycans  directs oxidative damage 
towards these biopolymers[33,37,38].  
At sites of inflammation within the extracellular matrix, activated phagocytes release the 
haem enzyme myeloperoxidase and produce high concentrations of the superoxide anion  
and its dismutation product, hydrogen peroxide via an oxidative burst. Myeloperoxidase 
is a highly basic protein and is known to bind, via electrostatic interactions, to negatively 
charged materials such as the polyanionic glycosaminoglycans   [33]. In perlecan, for 
example, it binds to the heparin sulphate side-chains of this proteoglycan [34]. 
Myeloperoxidase reacts with hydrogen peroxide to form a mixture of hypochlorous acid 
and its anion hypochlorite. Developments in the understanding of the biochemistry of 
myeloperoxidase, the oxidants that this enzyme generates, and the use of inhibitors to 
inhibit such damage have been reviewed recently [35]. 
Relatively high concentrations of HOCl are likely to be formed in vivo under both 
physiological and pathological conditions. It has been estimated , for example, that 
activation of 5×106 neutrophil cells ml-1 generates 300–400 μM HOCl over 1–2 hours 
[39,40], with 2.5–5 mM HOCl produced at sites of inflammation [41]. It is known that 
hypochlorous species , in particular HOCl, react rapidly at rates up to 108 M-1 s-1 with 
amino acids and peptides, with cysteine and methionine being amongst the most reactive 
[29, 42] . In a homogeneous distribution of HOCl and the heparan sulphate 
proteoglycans, glypican-1 and perlecan it has been estimated that most of the reactions 
occur at the protein core for ratios of HOCl : proteoglycan  ranging from < 1 up to 200.  
For glypican-1, as the ratio increases between 24 and 200, there is an increasing reaction 
at GlcNH2 residues in the heparan sulphate moiety [42]. Similarly, in the extracellular 
matrix, where hyaluronan has a central structural role, it can also be anticipated that 
HOCl will react preferentially with neighbouring proteins. There is thus little evidence 
for a direct reaction between hypochlorous species and reactive N-H groups in 
hyaluronan and heavily-sulphated glycosaminoglycans such as heparan sulphate. 
However, such a theoretical model does not take into account accessibility of the reactive 
N-H groups in proteins and glycosaminoglycans in an extracellular environment. Perhaps 
more importantly, it does not take into account the possibility of localized chlorination 
and oxidation reactions when the cationic myeloperoxidase itself is localized 
preferentially at glycosaminoglycan moieties in the extracellular matrix. Thus, it is 
difficult to exclude the direct formation of chloramides at the NHAc and NHSO3- groups 
in hyaluronan and heparin  respectively. At the lowered pHs at inflammation sites, HOCl 
(and not OCl-) will be the major reacting species. 
The main purpose of this study was to investigate both the kinetic reactivity and reaction 
profiles of the two species, HOCl and OCl-  with hyaluronan and with heparin, the latter 
being the most-heavily sulphated glycosaminoglycan. Hyaluronan is a significant 
component of the extracellular matrix and is unusual in that it is not found in vivo as a 
proteoglycan. These two biopolymers have large differences in charge density with 
heparin containing on average 2-3 sulphate groups per disaccharide unit whereas 
hyaluronan has one negative charge per disaccharide unit. This study was designed to 
provide a basis provide a basis for prediction of the modes of reaction of the hypochlorite 
species with glycosaminoglycans, particularly to differentiate the response of sulphated 
and non-sulphated glycosaminoglycans in the extracellular matrix and also to assess 
whether chloramide formation may accelerate fragmentation via subsequent site-specific 
oxidation by the hypochlorous species. 
This study has shown that charge density in glycosaminoglycans has a major effect in 
determining the mode of reaction of hypochlorite species and emphasises the dominant 
role of the N-sulphated group.  In the case of the non-sulphated and lightly-charged 
hyaluronan, this study shows that both oxidative damage (but little fragmentation) and 
chloramide formation are significant modes of reaction for hypochlorite species. At high 
levels of hypochlorite found at sites of inflammation, initial chloramide formation will be 
followed by further reaction with HOCl leading to fragmentation. For heparin, 
chloramide formation by HOCl at NHSO3- is an efficient process with little oxidation ( < 
5%) seen. Unlike hyaluronan, there is no evidence of subsequent reactions of the 
chloramide HOCl which would lead to fragmentation of the glycosaminoglycan. 
Reactions of OCl- with heparin are directly influenced by the N-sulphate group with 
lower yields of chloramide and a correspondingly higher yield of oxidation. In whatever 
way chloramides of glycosaminoglycans are formed in vivo, they are likely to be more 
susceptible to attack by both reactive oxidative species than the parent biopolymers and 
particularly by reducing species, including superoxide radicals, with high probability of 
site-specific reactions leading to efficient fragmentation of these important biopolymers 
of the extracellular matrix. 
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